| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |